The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 353:867-870 September 1, 2005 Number 9
NextNext

Newborn Screening — Setting Evidence-Based Policy for Protection
Marvin Natowicz, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
In the early 1960s, a Massachusetts program for testing neonates for phenylketonuria became the first organized effort to screen newborns for genetic or metabolic disease in order to identify treatable disorders before they became symptomatic. Since that time, newborn-screening programs have expanded to include additional genetic and nongenetic conditions and have been implemented in all U.S. states, as well as in other countries. Although the importance and clinical successes of such screening are well recognized, many issues in newborn-screening policy and practice remain controversial.1,2

Newborn screening in the United States is mandated and regulated by the states, with little direction . . . [Full Text of this Article]


Source Information

Dr. Natowicz is a medical geneticist and clinical pathologist at the Cleveland Clinic Foundation, Cleveland.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.